Inventor · disambiguated record
David W. Osborne
Also filed as: OSBORNE DAVID · OSBORNE DAVID W · OSBORNE DAVID WADE
70 granted patents·49 pending applications·2,524 citations·filing 1991–2025
99Inventor score
Files withARCUTIS BIOTHERAPEUTICS INC45ARCUTIS INC10VIROTEX CORP9PROBST BRIAN HULLINGER8QLT USA INC5
Top patents by PatentIndex Score
119 records- 0199US11819496B2Topical roflumilast formulation having improved delivery and plasma half-lifeARCUTIS BIOTHERAPEUTICS INC·Filed 2023·Granted Nov 21, 2023·17 cites·20 claims
- 0299US11793796B2Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2020·Granted Oct 24, 2023·18 cites·13 claims
- 0399US10940142B2Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2018·Granted Mar 9, 2021·19 cites·14 claims
- 0498US12005052B2Topical roflumilast formulation having improved delivery and plasma half-lifeARCUTIS BIOTHERAPEUTICS INC·Filed 2023·Granted Jun 11, 2024·3 cites·9 claims
- 0598US12005051B2Topical roflumilast formulation having improved delivery and plasma half lifeARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 11, 2024·4 cites·20 claims
- 0698US10105354B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Oct 23, 2018·23 cites·14 claims
- 0798US9907788B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Mar 6, 2018·31 cites·17 claims
- 0898US9895359B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Feb 20, 2018·35 cites·16 claims
- 0998US9884050B1Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Feb 6, 2018·30 cites·12 claims
- 1098US8467183B2Tablet computer case and associated methodsPROBST BRIAN HULLINGER·Filed 2011·Granted Jun 18, 2013·58 cites·19 claims
- 1198US7252816B1Topical acne vulgairs medication with a sunscreenDOW PHARMACEUTICAL SCIENCES·Filed 2006·Granted Aug 7, 2007·93 cites·42 claims
- 1298US5800832ABioerodable film for delivery of pharmaceutical compounds to mucosal surfacesVIROTEX CORP·Filed 1996·Granted Sep 1, 1998·274 cites·1 claims
- 1397US12042487B2Method for reducing side effects from administration of phosphodiesterase-4 inhibitorsARCUTIS BIOTHERAPEUTICS INC·Filed 2023·Granted Jul 23, 2024·4 cites·30 claims
- 1497US11992480B2Method for reducing side effects from administration of phosphodiesterase-4 inhibitorsARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Granted May 28, 2024·8 cites·43 claims
- 1597US10172841B2Inhibition of crystal growth of roflumilastARCUTIS INC·Filed 2017·Granted Jan 8, 2019·21 cites·19 claims
- 1697US8472186B2Tablet computer case and associated methodsPROBST BRIAN HULLINGER·Filed 2011·Granted Jun 25, 2013·28 cites·18 claims
- 1797US8467178B2Tablet computer case and associated methodsPROBST BRIAN HULLINGER·Filed 2011·Granted Jun 18, 2013·37 cites·23 claims
- 1896US12310956B2Topical roflumilast formulation having improved delivery and plasma half-lifeARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Granted May 27, 2025·1 cites·22 claims
- 1996US11730740B2Laureth-4 containing topical formulationsARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·2 cites·16 claims
- 2096US11534493B2Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solventsARCUTIS INC·Filed 2017·Granted Dec 27, 2022·19 cites·2 claims
- 2196US11129818B2Topical roflumilast formulation having improved delivery and plasma half lifeARCUTIS INC·Filed 2020·Granted Sep 28, 2021·21 cites·14 claims
- 2296USD676449STablet computer caseCRUXCASE LLC·Filed 2011·Granted Feb 19, 2013·151 cites·1 claims
- 2396US7579019B2Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfacesARIUS TWO INC·Filed 2005·Granted Aug 25, 2009·134 cites·7 claims
- 2496US6159498ABioerodable film for delivery of pharmaceutical compounds of mucosal surfacesVIROTEX CORP·Filed 1998·Granted Dec 12, 2000·147 cites·27 claims
- 2596US6103266APharmaceutical gel preparation applicable to mucosal surfaces and body tissuesFiled 1998·Granted Aug 15, 2000·230 cites·37 claims
- 2695US5863560ACompositions and methods for topical application of therapeutic agentsVIROTEX CORP·Filed 1996·Granted Jan 26, 1999·107 cites·10 claims
- 2795US5776430ATopical antimicrobial cleanser containing chlorhexidine gluconate and alcoholCALGON VESTAL INC·Filed 1994·Granted Jul 7, 1998·148 cites·17 claims
- 2893USD753123STablet computer caseZAGG IP HOLDING CO INC·Filed 2014·Granted Apr 5, 2016·45 cites·1 claims
- 2993US8472177B2Tablet computer case and associated methodsPROBST BRIAN HULLINGER·Filed 2011·Granted Jun 25, 2013·16 cites·32 claims
- 3093US6060085ACompositions and methods for topical application of therapeutic agentsFiled 1998·Granted May 9, 2000·92 cites·16 claims
- 3192US12336983B2Inhibition of crystal growth of roflumilastARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·0 cites·29 claims
- 3292US11707454B2Topical roflumilast formulation having antifungal propertiesARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Granted Jul 25, 2023·16 cites·17 claims
- 3392US8467179B2Tablet computer case and associated methodsPROBST BRIAN HULLINGER·Filed 2011·Granted Jun 18, 2013·22 cites·14 claims
- 3492US6432415B1Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfacesAXRIX LAB INC·Filed 1999·Granted Aug 13, 2002·156 cites·43 claims
- 3591US11628177B2Compositions and methods for deep dermal drug deliveryARCUTIS BIOTHERAPEUTICS INC·Filed 2021·Granted Apr 18, 2023·2 cites·16 claims
- 3691US8467185B2Tablet computer case and associated methodsPROBST BRIAN HULLINGER·Filed 2011·Granted Jun 18, 2013·12 cites·24 claims
- 3791US5955097APharmaceutical preparation applicable to mucosal surfaces and body tissuesVIROTEX CORP·Filed 1996·Granted Sep 21, 1999·90 cites·17 claims
- 3890US12016848B2Roflumilast formulations with an improved pharmacokinetic profileARCUTIS BIOTHERAPEUTICS INC·Filed 2023·Granted Jun 25, 2024·3 cites·12 claims
- 3990US12011437B1Roflumilast formulations with an improved pharmacokinetic profileARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Granted Jun 18, 2024·3 cites·19 claims
- 4089US12257242B2Inhibition of crystal growth of roflumilastARCUTIS BIOTHERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·0 cites·25 claims
- 4188US12220409B2Roflumilast formulations with an improved pharmacokinetic profileARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Granted Feb 11, 2025·1 cites·30 claims
- 4288US8590698B1Eyewear storage cases and related methodsOSBORNE DAVID W·Filed 2011·Granted Nov 26, 2013·24 cites·18 claims
- 4388USD679277STablet computer casePROBST BRIAN HULLINGER·Filed 2011·Granted Apr 2, 2013·34 cites·1 claims
- 4487US12390453B2Method for reducing side effects from administration of phosphodiesterase-4 inhibitorsARCUTIS BIOTHERAPEUTICS INC·Filed 2024·Granted Aug 19, 2025·0 cites·23 claims
- 4587US12042558B2Method and formulation for improving roflumilast skin penetration lag timeARCUTIS BIOTHERAPEUTICS INC·Filed 2019·Granted Jul 23, 2024·3 cites·6 claims
- 4687US7326408B2Topical acne vulgaris medication with a sunscreenDOW PHARMACEUTICAL SCIENCES·Filed 2007·Granted Feb 5, 2008·9 cites·21 claims
- 4787US2025235435A1Inhibition of crystal growth of roflumilastARCUTIS BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4885US12083122B2Laureth-4 containing topical formulationsARCUTIS BIOTHERAPEUTICS INC·Filed 2023·Granted Sep 10, 2024·0 cites·14 claims
- 4985US5905092ATopical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contractionVIROTEX CORP REEL FRAME·Filed 1997·Granted May 18, 1999·97 cites·34 claims
- 5084US8124123B2Controlled release azithromycin solid dosages formsPILLAI RADHAKRISHNAN·Filed 2007·Granted Feb 28, 2012·9 cites·48 claims
Showing the top 50 of 119 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David W. Osborne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →